Sunoqrot, Mohammed R. S. http://orcid.org/0000-0001-9239-1683
Saha, Anindo
Hosseinzadeh, Matin
Elschot, Mattijs
Huisman, Henkjan
Funding for this research was provided by:
The Research Council of Norway (295013, 295013)
The Norwegian Cancer Society and Prostatakreftforeningen (215951, 215951)
The Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology (90265300)
The Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology (90793700)
EU H2020 ProCAncer-I (952159, Number)
EU H2020 PANCAIM (101016851)
EU IMI2 PIONEE (777492)
EU IMI2 PIONEER (777492)
NTNU Norwegian University of Science and Technology
Article History
Received: 8 March 2022
Accepted: 9 May 2022
First Online: 1 August 2022
Declarations
:
: Not applicable.
: Not applicable.
: Henkjan Huisman declares to receive research support from Siemens Healthineers, the other authors declare that they have no competing interests.